The effect of gapentin cream on pruritus in dialysis patients
Phase 3
- Conditions
- Itching end-stage renal disease leading to dialysis.Pruritus
- Registration Number
- IRCT20220306054206N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Target community patients with pruritus ani. The itching studied in this study should be itching of the whole body except the head, face and neck.
Exclusion Criteria
Itching of the head, neck and face
Other simultaneous skin diseases on the trunk and limbs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determining the effectiveness of gabapentin topical cream in improving itching in dialysis patients. Timepoint: Patients receive medication for 4 weeks and are followed up for 4 weeks thereafter. Method of measurement: Two questionnaires are used to score patients' pruritus: 12-item and 5-item.
- Secondary Outcome Measures
Name Time Method Determining the mean changes in pruritus score before and after application of Gabapentin topical cream according to age and sex, duration of dialysis initiation and underlying cause of dialysis. Timepoint: Patients receive medication for 4 weeks and are followed up for 4 weeks thereafter. Method of measurement: By two questionnaires: 12-item and 5-item.